These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 21304148

  • 1. The efficacy and safety of fentanyl buccal tablet compared with immediate-release oxycodone for the management of breakthrough pain in opioid-tolerant patients with chronic pain.
    Ashburn MA, Slevin KA, Messina J, Xie F.
    Anesth Analg; 2011 Mar; 112(3):693-702. PubMed ID: 21304148
    [Abstract] [Full Text] [Related]

  • 2. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM, Messina J, Xie F, Hale M.
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [Abstract] [Full Text] [Related]

  • 3. Fentanyl buccal tablet compared with immediate-release oxycodone for the management of breakthrough pain in opioid-tolerant patients with chronic cancer and noncancer pain: a randomized, double-blind, crossover study followed by a 12-week open-label phase to evaluate patient outcomes.
    Webster LR, Slevin KA, Narayana A, Earl CQ, Yang R.
    Pain Med; 2013 Sep; 14(9):1332-45. PubMed ID: 23855816
    [Abstract] [Full Text] [Related]

  • 4. A novel 12-week study, with three randomized, double-blind placebo-controlled periods to evaluate fentanyl buccal tablets for the relief of breakthrough pain in opioid-tolerant patients with noncancer-related chronic pain.
    Farrar JT, Messina J, Xie F, Portenoy RK.
    Pain Med; 2010 Sep; 11(9):1313-27. PubMed ID: 20807345
    [Abstract] [Full Text] [Related]

  • 5. Long-term safety and tolerability of fentanyl buccal tablet for the treatment of breakthrough pain in opioid-tolerant patients with chronic pain: an 18-month study.
    Fine PG, Messina J, Xie F, Rathmell J.
    J Pain Symptom Manage; 2010 Nov; 40(5):747-60. PubMed ID: 20594801
    [Abstract] [Full Text] [Related]

  • 6. Long-term dosing, safety, and tolerability of fentanyl buccal tablet in the management of noncancer-related breakthrough pain in opioid-tolerant patients.
    Nalamachu SR, Narayana A, Janka L.
    Curr Med Res Opin; 2011 Apr; 27(4):751-60. PubMed ID: 21288055
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fentanyl buccal tablet for relief of breakthrough pain in opioid-tolerant patients with cancer-related chronic pain.
    Slatkin NE, Xie F, Messina J, Segal TJ.
    J Support Oncol; 2007 Apr; 5(7):327-34. PubMed ID: 17708123
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of fentanyl buccal tablet on pain-related anxiety: a 4-week open-label study among opioid-tolerant patients with chronic and breakthrough pain.
    Webster LR, Messina J, Xie F, Nalamachu S.
    J Opioid Manag; 2011 Apr; 7(4):297-308. PubMed ID: 21957829
    [Abstract] [Full Text] [Related]

  • 11. Aberrant drug-related behavior observed during a 12-week open-label extension period of a study involving patients taking chronic opioid therapy for persistent pain and fentanyl buccal tablet or traditional short-acting opioid for breakthrough pain.
    Passik SD, Narayana A, Yang R.
    Pain Med; 2014 Aug; 15(8):1365-72. PubMed ID: 24666664
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Fentanyl buccal tablet for the treatment of breakthrough pain in opioid-tolerant patients with chronic cancer pain: A long-term, open-label safety study.
    Weinstein SM, Messina J, Xie F.
    Cancer; 2009 Jun 01; 115(11):2571-9. PubMed ID: 19373888
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A randomized, double-blind, placebo-controlled study of fentanyl buccal tablets for breakthrough pain: efficacy and safety in Japanese cancer patients.
    Kosugi T, Hamada S, Takigawa C, Shinozaki K, Kunikane H, Goto F, Tanda S, Shima Y, Yomiya K, Matoba M, Adachi I, Yoshimoto T, Eguchi K.
    J Pain Symptom Manage; 2014 Jun 01; 47(6):990-1000. PubMed ID: 24099893
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.